Rat Model Global Market Report 2023 - Partnerships and High Growth in Biomedical Research Propel the Industry Forward

Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Rat Model Global Market Report 2023" has been added to ResearchAndMarkets.com's offering.

The rat model market is expected to reach $2.13 billion in 2027 at a CAGR of 8.1%. This report focuses on rat model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

The rise in demand for medicines is expected to propel the growth of the rat model market in the coming future. Rat models help researchers to conduct research on various medicines as they are easier to feed and smaller in size than other complex mammals, such as primates, and is a more convenient option, as a result, rise in demand for medicines increases the demand for rat models market. For instance, according to the European Federation of Pharmaceutical Industries and Associations, a Belgium-based pharmaceutical industries association, in 2021, North America was responsible for 49.1% of global pharmaceutical sales, compared to Europe's 23.4%. Therefore, the rise in demand for medicines is driving the rat model market.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. - The market characteristics section of the report defines and explains the market.

  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.


Markets Covered:

1) By Type: Knockout; Outbred; Inbred; Hybrid; Immunodeficient; Conditioned
2) By Service: Cryopreservation; Breeding; Re-derivation; Genetic Testing; Quarantine Depending; Other Services
3) By Technology: Nuclear Transferase; Microinjection; Embryonic Stem Cell; Other Technologies
4) By Application: Oncology; Neurology; Immunology; Toxicology; Other Applications

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Key Attributes:

Report AttributeDetails
No. of Pages275
Forecast Period2023 - 2027
Estimated Market Value (USD) in 2023$1.56 billion
Forecasted Market Value (USD) by 2027$2.13 billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal

Companies profiled:

  • Genoway S.A.
  • Biomere
  • Transposagen Biopharmaceuticals Inc.
  • Horizon Discovery Group PLC
  • Transviragen Inc.
  • Charles River Laboratories International Inc.
  • Taconic Biosciences Inc.
  • Envigo Ltd.
  • Laboratory Corporation of America Holdings
  • Janvier Labs
  • Harlan Laboratories Inc.
  • Sage Path Labs
  • Applied StemCell Inc.
  • Regenera Pharma Ltd.
  • Taconic Biosciences Inc.

For more information about this report visit https://www.researchandmarkets.com/r/mpj611

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Rat Model Market

Contact Data